Trial site
Children's Health Ireland
- 12running trials
- 3closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers5 trials
- Acute lymphoblastic leukaemia3 trials
- Ulcerative colitis3 trials
- Acute myeloid leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Congenital heart disease1 trial
- Crohn's disease1 trial
- Down syndrome1 trial
- Epidermolysis bullosa1 trial
- Heart failure1 trial
- Hypertrophic cardiomyopathy1 trial
- Obstructive sleep apnoea1 trial
- Phase
- Phase 39 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Alfasigma S.p.A.2 trials
- Bayer1 trial
- Bristol-Myers Squibb1 trial
- Children's Health Ireland1 trial
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)1 trial
- and 9 more
Running trials
Recruiting
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Recruiting
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Recruiting
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
Recruiting
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Childhood cancers2 recruiting
- Congenital heart disease1 recruiting
- Crohn's disease1 recruiting
- Down syndrome1 recruiting
- Epidermolysis bullosa1 recruiting
- Obstructive sleep apnoea1 recruiting
Closed trials
Completed
Active, not recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026